Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen

被引:49
|
作者
Gueguen, M [1 ]
Long, EO [1 ]
机构
[1] NIAID,IMMUNOGENET LAB,NIH,ROCKVILLE,MD 20852
关键词
antigen processing; HLA-DR; N-end rule; protein degradation; ubiquitin;
D O I
10.1073/pnas.93.25.14692
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Class I and class II molecules of the major histocompatibility complex present peptides to T cells, Class I molecules bind peptides that hare been generated in the cytosol by proteasomes and delivered into the endoplasmic reticulum by the transporter associated with antigen presentation, In contrast, class II molecules are very efficient in the presentation of antigens that have been internalized and processed in endosomal lysosomal compartments, In addition, class II molecules can present some cytosolic antigens by a TAP-independent pathway. To test whether this endogenous class II presentation pathway was linked to proteasome-mediated degradation of antigen in the cytosol, the N-end rule was utilized to produce two forms of the influenza virus matrix protein with different in vivo half-lives (10 min vs. 5 h) when expressed in human B cells, Whereas class I molecules presented both the short- and the long-lived matrix proteins, class II molecules presented exclusively the long-lived form of antigen, Thus, rapid degradation of matrix protein in the cytosol precluded its presentation by class II molecules, These data suggest that the turnover of long-lived cytosolic proteins, some of which is mediated by delivery into endosomal/lysosomal compartments, provides a mechanism for immune surveillance by CD4(+) T cells.
引用
收藏
页码:14692 / 14697
页数:6
相关论文
共 50 条
  • [31] Major histocompatibility complex class I-restricted antigen processing and presentation
    Van Kaer, L
    TISSUE ANTIGENS, 2002, 60 (01): : 1 - 9
  • [32] DELIVERY OF PROTEIN ANTIGEN TO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGEN PRESENTATION PATHWAY
    ZHOU, F
    HUANG, L
    JOURNAL OF DRUG TARGETING, 1995, 3 (02) : 91 - 109
  • [33] IDENTIFICATION OF CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX POLYMORPHISMS PREDICTED TO BE IMPORTANT IN PEPTIDE ANTIGEN PRESENTATION
    PHARR, GT
    HUNT, HD
    BACON, LD
    DODGSON, JB
    POULTRY SCIENCE, 1993, 72 (07) : 1312 - 1317
  • [34] Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells
    Haraldsen, G
    Sollid, LM
    Bakke, O
    Farstad, IN
    Kvale, D
    Molberg, O
    Norstein, J
    Stang, E
    Brandtzaeg, P
    GASTROENTEROLOGY, 1998, 114 (04) : 649 - 656
  • [35] Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
    Deussing, J
    Roth, W
    Saftig, P
    Peters, C
    Ploegh, HL
    Villadangos, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4516 - 4521
  • [36] Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation
    La Flamme, AC
    Kahn, SJ
    Rudensky, AY
    Van Voorhis, WC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3085 - 3094
  • [37] Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's diseasetumor cells
    Bosshart, H
    Jarrett, RF
    BLOOD, 1998, 92 (07) : 2252 - 2259
  • [38] A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation
    Perry, VH
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 90 (02) : 113 - 121
  • [39] Double stranded deoxyribonucleic acid binds to human histocompatibility leukocyte antigen class II molecules and inhibits human histocompatibility leukocyte antigen class II mediated antigen presentation
    Filaci, G
    Contini, P
    Grasso, I
    Bignardi, D
    Ghio, M
    Lanza, L
    Scudeletti, M
    Puppo, F
    Bolognesi, M
    Accolla, RS
    Indiveri, F
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 355 - 359
  • [40] Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
    Andersen, Tor Kristian
    Huszthy, Peter C.
    Gopalakrishnan, Ramakrishna P.
    Jacobsen, Johanne T.
    Fauskanger, Marte
    Tveita, Anders A.
    Grodeland, Gunnveig
    Bogen, Bjarne
    NPJ VACCINES, 2019, 4 (1)